Top

Published in:

27-07-2023 | Heart Failure

Heart Failure in the Elderly: the Role of Biological and Sociocultural Aspects Related to Sex

Authors: Pablo Díez-Villanueva, César Jiménez-Méndez, María Thiscal López-Lluva, Samantha Wasniewski, Jorge Solís, Leticia Fernández-Friera, Manuel Martínez-Sellés

Published in: Current Heart Failure Reports | Issue 5/2023

Abstract

Purpose of Review

Heart failure (HF) entails poor prognosis, with high morbidity and mortality burden, particularly in elderly patients. Notably, important sex differences have been described between men and women with HF. In this regard, some biological and sociocultural aspects related to sex may play a key role in the different development and prognosis of HF in elderly men and women.

Recent Findings

Important differences between men and women with HF, especially in the elderly population, have been specifically addressed in recent studies. Consequently, specific differences in biological and sociocultural aspects have been found to associate differences in pathophysiology, baseline clinical profile, and prognosis according to sex. Moreover, differences in comorbidities and frailty and other geriatric conditions, frequent in elderly population with HF, have also been described.

Summary

Biological and sociocultural differences related to sex are key in the different clinical presentation and prognosis of heart failure in elderly women. Further studies will be required to better understand some other underlying reasons that may differently impact prognosis in elderly patients with HF.

Garcia M, Mulvagh SL, Merz NB, Buring JE, Manson JE. Cardiovascular disease in women: clinical perspectives. Circ Res. 2016;118(8):1273–93. https://doi.org/10.1161/CIRCRESAHA.116.307547.CrossRefPubMedPubMedCentral

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24(1):4–131. https://doi.org/10.1002/ejhf.2333.CrossRefPubMed

Díez-Villanueva P, Jiménez-Méndez C, Alfonso F. Heart failure in the elderly. J Geriatr Cardiol. 2021;18(3):219–32. https://doi.org/10.11909/j.issn.1671-5411.2021.03.009.CrossRefPubMedPubMedCentral

Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63:1123–33.CrossRefPubMed

Benjamin EJ, Muntner P, Alonso A, Bittencourt M, Callaway W, Carson A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–66.CrossRefPubMed

Magnussen C, Niiranen TJ, Ojeda FM, Gianfagna F, Blankenberg S, Vartiainen E. Sex specific epidemiology of heart failure risk and mortality in Europe. JACC Hear Fail. 2019;7(3):204–13.CrossRef

Marra AM, Salzano A, Arcopinto M, Piccioli L, Raparelli V. The impact of gender in cardiovascular medicine: lessons from the gender/sex-issue in heart failure. Arch Chest Dis. 2018;88(3):988.

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38–360.PubMed

•• Díez-Villanueva P, Jiménez-Méndez C, Bonanad C, Ortiz-Cortés C, Barge-Caballero E, Goirigolzarri J, et al. Sex differences in the impact of frailty in elderly outpatients with heart failure. Front Cardiovasc Med. 2022;9:1000700. https://doi.org/10.3389/fcvm.2022.1000700. This study briefly highlights sex differences in a cohort of chronic heart failure elderly patients. The authors specifically address the impact of frailty and other geriatric conditions regarding sex in this population.CrossRefPubMedPubMedCentral

10.

Postigo A, Martínez-Sellés M. Sex influence on heart failure prognosis. Front Cardiovasc Med. 2020;21(7):616273. https://doi.org/10.3389/fcvm.2020.616273.CrossRef

11.

Daubert MA, Douglas PS. Primary prevention of heart failure in women. JACC Hear Fail. 2019;7(3):181–91.CrossRef

12.

Suthahar N, Meems LMG, Ho JE, de Boer RA. Sex-related differences in contemporary biomarkers for heart failure: a review. Eur J Heart Fail. 2020;22(5):775–88. https://doi.org/10.1002/ejhf.1771.CrossRefPubMed

13.

•• Lala A, Tayal U, Hamo CE, Youmans Q, Al-Khatib SM, Bozkurt B, et al. Sex differences in heart failure. J Card Fail. 2022;3:477–98. https://doi.org/10.1016/j.cardfail.2021.10.006. The role of specific women-related heart failure risk factors is widely addressed in this review article. It highlights gaps in knowledge with calls to action for future research.CrossRef

14.

Dewan P, Rørth R, Jhund PS, Shen L, Raparelli V, Petrie MC, et al. Differential impact of heart failure with reduced ejection fraction on men and women. J Am Coll Cardiol. 2019;73(1):29–40.CrossRefPubMed

15.

Levinsson A, Dube MP, Tardif JC, de Denus S. Sex, drugs, and heart failure: a sex-sensitive review of the evidence base behind current heart failure clinical guidelines. ESC Heart Fail. 2018;5(5):745–54.CrossRefPubMedPubMedCentral

16.

Díez-Villanueva P, Jiménez-Méndez C, Bonanad C, García-Blas S, Pérez-Rivera A, Allo G, et al. Risk factors and cardiovascular disease in the elderly. Rev Cardiovasc Med. 2022;23(6):188.CrossRef

17.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. https://doi.org/10.1093/eurheartj/ehy339.CrossRefPubMed

18.

Ji H, Niiranen TJ, Rader F, Henglin M, Kim A, Ebinger JE, et al. Sex differences in blood pressure associations with cardiovascular outcomes. Circulation. 2021;143(7):761–3. https://doi.org/10.1161/CIRCULATIONAHA.120.049360.CrossRefPubMedPubMedCentral

19.

•• Regensteiner JG, Reusch JEB. Sex differences in cardiovascular consequences of hypertension, obesity, and diabetes. J Am Coll Cardiol. 2022;79(15):1492–505. https://doi.org/10.1016/j.jacc.2022.02.010. This review article summarizes gender disparities in the effect of traditional cardiovascular risk factors.CrossRefPubMedPubMedCentral

20.

Muiesan ML, Salvetti M, Rosei CA, Paini A. Gender differences in antihypertensive treatment: myths or legends? High Blood Press Cardiovasc Prev. 2016 Jun;23(2):105–13. https://doi.org/10.1007/s40292-016-0148-1.CrossRefPubMed

21.

Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021 May 25;143(21):e984–e1010.PubMedPubMedCentral

22.

Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017-2018. NCHS Data Brief. 2020;360:1–8.

23.

Goossens GH, Jocken JWE, Blaak EE. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;1:47–66. https://doi.org/10.1038/s41574-020-00431-8.CrossRef

24.

Savji N, Meijers WC, Bartz TM, Bhambhani V, Cushman M, Nayor M, et al. The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC Heart Fail. 2018;8:701–9. https://doi.org/10.1016/j.jchf.2018.05.018.CrossRef

25.

Horwich TB, Fonarow GC, Clark AL. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis. 2018;61:151–6.CrossRefPubMed

26.

Streng KW, Voors AA, Hillege HL, Anker SD, Cleland JG, Dickstein K, et al. Waist-to-hip ratio and mortality in heart failure. Eur J Heart Fail. 2018;20:1269–127.CrossRefPubMed

27.

Al-Salameh A, Chanson P, Bucher S, Ringa V, Becquemont L. Cardiovascular disease in type 2 diabetes: a review of sex-related differences in predisposition and prevention. Mayo Clin Proc. 2019;2:287–308.CrossRef

28.

Woodward M. Cardiovascular disease and the female disadvantage. Int J Environ Res Public Health. 2019;16(7):1165. https://doi.org/10.3390/ijerph16071165.CrossRefPubMedPubMedCentral

29.

Díez-Villanueva P, García-Acuña JM, Raposeiras-Roubin S, Barrabés JA, Cordero A, Martínez-Sellés M, et al. Prognosis impact of diabetes in elderly women and men with non-ST elevation acute coronary syndrome. J Clin Med. 2021;10(19):4403. https://doi.org/10.3390/jcm10194403.CrossRefPubMedPubMedCentral

30.

Welty FK. Cardiovascular disease and dyslipidemia in women. Arch Intern Med. 2001;161(4):514–22.CrossRefPubMed

31.

Robinson GA, Pineda-Torra I, Ciurtin C, Jury EC. Sex differences in lipid metabolism: implications for systemic lupus erythematosus and cardiovascular disease risk. Front Med (Lausanne). 2022;9:914016. https://doi.org/10.3389/fmed.2022.914016.CrossRefPubMedPubMedCentral

32.

Martínez-Sellés M, Díez-Villanueva P, Álvarez Garcia J, Ferrero-Gregori A, Vives-Borrás M, Worner F, et al. Influence of sex and pregnancy on survival in patients admitted with heart failure: data from a prospective multicenter registry. Clin Cardiol. 2018;41(7):924–30. https://doi.org/10.1002/clc.22979.CrossRefPubMedPubMedCentral

33.

Honigberg MC, Zekavat SM, Aragam K, Klarin D, Bhatt D, Scott N, et al. Long-term cardiovascular risk in women with hypertension during pregnancy. J Am Coll Cardiol. 2019;74:2743–54.CrossRefPubMedPubMedCentral

34.

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M. et al; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227–337.CrossRefPubMed

35.

Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773–9.CrossRefPubMed

36.

Echouffo-Tcheugui JB, Guan J, Retnakaran R, Shah BR. Gestational diabetes and incident heart failure: a cohort study. Diabetes Care. 2021;12:cd210552.

37.

Shin J, Han K, Jung JH, Park HJ, Kim W, Huh Y, et al. Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study. Eur Heart J. 2022; https://doi.org/10.1093/eurheartj/ehac364.

38.

•• Khan SS, Beach LB, Yancy CW. Sex-based differences in heart failure: JACC Focus Seminar 7/7. J Am Coll Cardiol. 2022;79(15):1530–41. https://doi.org/10.1016/j.jacc.2022.02.013. Extensive review of sex-based differences in heart failure, from physiology to treatment.CrossRefPubMed

39.

Sliwa K, van der Meer P, Petrie MC, Frogoudaki A, Johnson MR, Hilfiker-Kleiner D, et al. Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2021;4:527–40. https://doi.org/10.1002/ejhf.2133.CrossRef

40.

Goli R, Li J, Brandimarto J, Levine LD, Riis V, McAfee Q, et al. Genetic and phenotypic landscape of peripartum cardiomyopathy. Circulation. 2021;143(19):1852–62. https://doi.org/10.1161/CIRCULATIONAHA.120.052395.CrossRefPubMedPubMedCentral

41.

Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med. 2016;374(3):233–41. https://doi.org/10.1056/NEJMoa1505517.CrossRefPubMedPubMedCentral

42.

Rasmusson K, Brunisholz K, Budge D, Horne BD, Alharethi R, Folsom J, et al. Peripartum cardiomyopathy: post-transplant outcomes from the United Network for Organ Sharing Database. J Heart Lung Transplant. 2012;31(2):180–6.CrossRefPubMed

43.

Jackson AM, Petrie MC, Frogoudaki A, Laroche C, Gustafsson F, Ibrahim B, et al. PPCM Investigators Group. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry. Eur J Heart Fail. 2021;(12):2058–69. https://doi.org/10.1002/ejhf.2264.

44.

Shachar SS, Hurria A, Muss HB. Breast cancer in women older than 80 years. J Oncol Pract. 2016;12(2):123–32. https://doi.org/10.1200/JOP.2015.010207.CrossRefPubMed

45.

Zagar TM, Cardinale DM, Marks LB. Breast cancer therapy-associated cardiovascular disease. Nature Rev Clin Oncol. 2016;13:172–84.CrossRef

46.

Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229–361. https://doi.org/10.1093/eurheartj/ehac244.CrossRefPubMed

47.

Podlesnikar T, Berlot B, Dolenc J, Goričar K, Marinko T. Radiotherapy-induced cardiotoxicity: the role of multimodality cardiovascular imaging. Front Cardiovasc Med. 2022;28(9):887705. https://doi.org/10.3389/fcvm.2022.887705.CrossRef

48.

Pfeffer TJ, Schlothauer S, Pietzsch S, Schaufelberger M, Auber B, Ricke-Hoch M, et al. Increased cancer prevalence in peripartum cardiomyopathy. JACC CardioOncol. 2019;1(2):196–205. https://doi.org/10.1016/j.jaccao.2019.09.008.CrossRefPubMedPubMedCentral

49.

Beale AL, Meyer P, Marwick TH, Lam CSP, Kaye DM. Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction. Circulation. 2018;138:198–205. https://doi.org/10.1161/CIRCULATIONAHA.118.034271.CrossRefPubMed

50.

Moran CA, Collins LF, Beydoun N, Mehta PK, Fatade Y, Isiadinso I, et al. Cardiovascular implications of immune disorders in women. Circ Res. 2022;130(4):593–610. https://doi.org/10.1161/CIRCRESAHA.121.319877.CrossRefPubMedPubMedCentral

51.

Stolfo D, Uijl A, Vedin O, Strömberg A, Faxén UL, Rosano GMC, et al. Sex-based differences in heart failure across the ejection fraction spectrum: phenotyping, and prognostic and therapeutic implications. JACC Heart Fail. 2019;6:505–15. https://doi.org/10.1016/j.jchf.2019.03.011.CrossRef

52.

Chang PP, Wruck LM, Shahar E, Rossi JS, Loehr LR, Russell SD, et al. Trends in hospitalizations and survival of acute decompensated heart failure in four US communities (2005-2014): ARIC Study Community Surveillance. Circulation. 2018;138(1):12–24. https://doi.org/10.1161/CIRCULATIONAHA.117.027551.CrossRefPubMedPubMedCentral

53.

Martínez-Sellés M, Ayesta A, Díaz-Molina B, Bayes-Genis A, Baranchuk A. Editorial: The role of sex in heart failure and transplantation. Front Cardiovasc Med. 2021;25(8):690438. https://doi.org/10.3389/fcvm.2021.690438.CrossRef

54.

Rossi A, Mikail N, Bengs S, Haider A, Treyer V, Buechel RR, et al. Heart-brain interactions in cardiac and brain diseases: why sex matters. Eur Heart J. 2022;43(39):3971–80. https://doi.org/10.1093/eurheartj/ehac061.CrossRefPubMedPubMedCentral

55.

Martínez-Sellés M, Domínguez M, Martínez E, García Fernández MA, García E. Women with left ventricular ejection fraction ≤ 20% have better prognosis than men. Int J Cardiol. 2007;120(2):276–8. https://doi.org/10.1016/j.ijcard.2006.07.195.CrossRefPubMed

56.

Martínez-Sellés M, García Robles JA, Prieto L, Domínguez Muñoa M, Frades E, Díaz-Castro O, et al. Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure. Eur Heart J. 2003;24(22):2046–53. https://doi.org/10.1016/j.ehj.2003.07.007.CrossRefPubMed

57.

Kajimoto K, Minami Y, Sato N, Otsubo S, Kasanuki H. Acute Decompensated Heart Failure Syndromes (ATTEND) registry. Gender differences in left ventricular ejection fraction and outcomes among patients hospitalized for acute decompensated heart failure. Am J Cardiol. 2017;119(10):1623–30. https://doi.org/10.1016/j.amjcard.2017.02.012.CrossRefPubMed

58.

Vicent L, Guerra J, Vazquez-García R, Gonzalez-Juanatey JR, Dolz LM, Segovia J, et al. Ischemic etiology and prognosis in men and women with acute heart failure. J Clin Med. 2021;10(8):1713. https://doi.org/10.3390/jcm10081713.CrossRefPubMedPubMedCentral

59.

Pérez-Castellanos A, Martínez-Sellés M, Mejía-Rentería H, Andrés M, Sionis A, Almendro-Delia M, et al. Tako-tsubo syndrome in men: rare, but with poor prognosis. Rev Esp Cardiol (Engl Ed). 2018;71(9):703–8. https://doi.org/10.1016/j.rec.2017.07.021.CrossRefPubMed

60.

Lam CSP, Arnott C, Beale AL, Chandramouli C, Hilfiker-Kleiner D, Kaye DM, et al. Sex differences in heart failure. Eur Heart J. 2019;40:3859–3868c.CrossRefPubMed

61.

Vicent L, Ayesta A, Esteban-Fernández A, Gómez-Bueno M, De-Juan J, Díez-Villanueva P, et al. Sex influence on the efficacy and safety of sacubitril/valsartan. Cardiology. 2019;142(2):73–8. https://doi.org/10.1159/000498984.CrossRefPubMed

62.

Nuechterlein K, AlTurki A, Ni J, Martínez-Sellés M, Martens P, Russo V, Backelin CN, et al. Real-world safety of sacubitril/valsartan in women and men with heart failure and reduced ejection fraction: a meta-analysis. CJC Open. 2021;3(12 Suppl):S202–8. https://doi.org/10.1016/j.cjco.2021.09.009.CrossRefPubMedPubMedCentral

63.

Merrill M, Sweitzer NK, Lindenfeld J, Kao DP. Sex differences in outcomes and responses to spironolactone in heart failure with preserved ejection fraction: a secondary analysis of TOPCAT trial. JACC Heart Fail. 2019;7:228–38.CrossRefPubMedPubMedCentral

64.

Wang X, Vaduganathan M, Claggett BL, Hegde SM, Pabon M, Kulac IJ, et al. Sex differences in characteristics, outcomes and treatment response with dapagliflozin across the range of ejection fraction in patients with heart failure: insights from DAPA-HF and DELIVER. Circulation. 2022; https://doi.org/10.1161/CIRCULATIONAHA.122.062832.

65.

Wang N, Evans J, Sawant S, Sindone J, Lal S. Sex-specific differences in the efficacy of heart failure therapies: a meta-analysis of 84,818 patients. Heart Fail Rev. 2022; https://doi.org/10.1007/s10741-022-10275-1.

66.

Díez-Villanueva P, Arizá-Solé A, Vidán MT, Bonanad C, Formiga F, Sanchis J, et al. Recommendations of the geriatric cardiology section of the Spanish society of cardiology for the assessment of frailty in elderly patients with heart disease. Rev Esp Cardiol. 2019;72:63–71. https://doi.org/10.1016/j.rec.2018.06.035.CrossRefPubMed

67.

•• Jiménez-Méndez C, Díez-Villanueva P, Bonanad C, Ortiz-Cortés C, Barge-Caballero E, Goirigolzarri J, et al. Frailty and prognosis of older patients with chronic heart failure. Rev Esp Cardiol (Engl Ed). 2022;S1885-5857(22):00155-4. https://doi.org/10.1016/j.rec.2022.04.016. This study analyzes the impact of frailty and other geriatric conditions in a cohort of elderly patients with chronic heart failure.CrossRef

68.

Denfeld QE, Winters-Stone K, Mudd JO, Gelow HM, Kurdi S, Lee CS. The prevalence of frailty in heart failure: a systematic review and meta-analysis. Int J Cardiol. 2017;236:283–9.CrossRefPubMedPubMedCentral

69.

Ayesta A, Valero Masa MJ, Vidán MT, Luna-López R, Segovia-Cubero J, et al. Prevalence and characterization of frailty, depression, and cognitive impairment in patients listed for heart transplantation: results of the FELICITAR prospective registry. Clin Transplant. 2021;35(9):e14391. https://doi.org/10.1111/ctr.14391.CrossRefPubMed

70.

Davis MR, Lee CS, Corcoran A, Gupta N, Uchmanowicz I, Denfeld QE. Gender differences in the prevalence of frailty in heart failure: a systematic review and meta-analysis. Int J Cardiol. 2021;333:133–40. https://doi.org/10.1016/j.ijcard.2021.02.062.CrossRefPubMedPubMedCentral

71.

Yang X, Lupón J, Vidán MT, Ferguson C, Gastelurrutia P, Newton PJ, et al. Impact of frailty on mortality and hospitalization in chronic heart failure: a systematic review and meta-analysis. J Am Heart Assoc. 2018;7(23):e008251. https://doi.org/10.1161/JAHA.117.008251.CrossRefPubMedPubMedCentral

72.

Lin H, Zhang H, Lin Z, Li X, Kong X, Sun G. Review of nutritional screening and assessment tools and clinical outcomes in heart failure. Heart Fail Rev. 2016;21(5):549–65. https://doi.org/10.1007/s10741-016-9540-0.CrossRefPubMed

73.

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. https://doi.org/10.1093/ageing/afy169.CrossRefPubMed

74.

Sayer AA, Cruz-Jentoft A. Sarcopenia definition, diagnosis and treatment: consensus is growing. Age Ageing. 2022;51(10):afac220. https://doi.org/10.1093/ageing/afac220.CrossRefPubMedPubMedCentral

75.

Tay L, Ding YY, Leung BP, Ismail NH, Yeo A, Yew S, Tay KS, Tan CH, Chong MS. Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults. Age (Dordr). 2015;37(6):121. https://doi.org/10.1007/s11357-015-9860-3.CrossRefPubMedPubMedCentral

76.

Dixon DD, Xu M, Akwo EA, Nair D, Schlundt D, Wang TJ, et al. Depressive symptoms and incident heart failure risk in the Southern Community Cohort Study. JACC Heart Fail. 2022;10(4):254–62. https://doi.org/10.1016/j.jchf.2021.11.007.CrossRefPubMedPubMedCentral

77.

Sbolli M, Fiuzat M, Cani D, O'Connor CM. Depression and heart failure: the lonely comorbidity. Eur J Heart Fail. 2020;22(11):2007–17. https://doi.org/10.1002/ejhf.1865.CrossRefPubMed

78.

Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail. 2007;9(5):440–9. https://doi.org/10.1016/j.ejheart.2006.11.001.CrossRefPubMed

79.

Vellone E, Chialà O, Boyne J, Klompstra L, Evangelista LS, Back M, et al. Cognitive impairment in patients with heart failure: an international study. ESC Heart Fail. 2020;7(1):46–53. https://doi.org/10.1002/ehf2.12542.CrossRefPubMed

80.

Yang M, Sun D, Wang Y, Yan M, Zheng J, Ren J. Cognitive impairment in heart failure: landscape, challenges, and future directions. Front Cardiovasc Med. 2022;7(8):831734. https://doi.org/10.3389/fcvm.2021.831734.CrossRef

81.

Gure TR, Blaum CS, Giordani B, Koelling TM, Galecki A, Pressler SJ, et al. Prevalence of cognitive impairment in older adults with heart failure. J Am Geriatr Soc. 2012;60(9):1724–9.CrossRefPubMedPubMedCentral

82.

Volgman AS, Bairey Merz CN, Aggarwal NT, Bittner V, Bunch TJ, Gorelick PB, et al. Sex differences in cardiovascular disease and cognitive impairment: another health disparity for women? J Am Heart Assoc. 2019;8(19):e013154. https://doi.org/10.1161/JAHA.119.013154.CrossRefPubMedPubMedCentral

83.

Levine DA, Gross AL, Briceño EM, Tilton N, Giordani BJ. Sussman JB, et al Sex differences in cognitive decline among US adults. JAMA Netw Open. 2021 Feb 1;4(2):e210169. https://doi.org/10.1001/jamanetworkopen.2021.0169.CrossRefPubMedPubMedCentral

84.

Sukumar S, Orkaby AR, Schwartz JB, Marcum Z, Januzzi JL, Vaduganathan M, Warraich HJ. Polypharmacy in older heart failure patients: a multidisciplinary approach. Curr Heart Fail Rep. 2022;19(5):290–302. https://doi.org/10.1007/s11897-022-00559-w.CrossRefPubMed

85.

Beezer J, Al Hatrushi M, Husband A, Kurdi A, Forsyth P. Polypharmacy definition and prevalence in heart failure: a systematic review. Heart Fail Rev. 2022;27(2):465–92. https://doi.org/10.1007/s10741-021-10135-4.CrossRefPubMed

86.

Rosano GM, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, et al. Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC. Eur Heart J. 2015;36(40):2677–80.CrossRefPubMed

87.

Bots SH, den Ruijter HM. Recommended heart failure medications and adverse drug reactions in women. Circulation. 2019;139(12):1469–71. https://doi.org/10.1161/CIRCULATIONAHA.118.037585.CrossRefPubMed

88.

Dodson JA, Chaudhry SI. Geriatric conditions in heart failure. Curr Cardiovasc Risk Rep. 2012;6(5):404–10. https://doi.org/10.1007/s12170-012-0259-8.CrossRefPubMedPubMedCentral

89.

Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, Franconi F, Gerdts E, Foryst-Ludwig A, et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016;37(1):24–34. https://doi.org/10.1093/eurheartj/ehv598.CrossRefPubMed

90.

Damiani G, Salvatori E, Silvestrini G, Ivanova I, Bojovic L, Iodice L, et al. Influence of socioeconomic factors on hospital readmissions for heart failure and acute myocardial infarction in patients 65 years and older: evidence from a systematic review. Clin Interv Aging. 2015;12(10):237–45. https://doi.org/10.2147/CIA.S71165.CrossRef

91.

Wong CW, Kwok CS, Narain A, Gulati M, Mihalidou AS, Wu P, et al. Marital status and risk of cardiovascular diseases: a systematic review and meta-analysis. Heart. 2018;104(23):1937–48. https://doi.org/10.1136/heartjnl-2018-313005.CrossRefPubMed

92.

Wang Y, Jiao Y, Nie J, O'Neil A, Huang W, Zhang L, et al. Sex differences in the association between marital status and the risk of cardiovascular, cancer, and all-cause mortality: a systematic review and meta-analysis of 7,881,040 individuals. Glob Health Res Policy. 2020;28(5):4. https://doi.org/10.1186/s41256-020-00133-8.CrossRef

93.

Kaiser P, Allen N, Delaney JAC, Hirsch CH, Carnethon M, Arnold AM, et al. The association of prediagnosis social support with survival after heart failure in the Cardiovascular Health Study. Ann Epidemiol. 2020;42:73–7. https://doi.org/10.1016/j.annepidem.2019.12.013.CrossRefPubMedPubMedCentral

94.

Schrage B, Lund LH, Benson L, Stolfo D, Ohlsson A, Westerling R, et al. Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure. Heart. 2021;107(3):229–36. https://doi.org/10.1136/heartjnl-2020-317216.CrossRefPubMed

95.

Lindberg F, Lund LH, Benson L, Schrage B, Edner M, Dahlström U, et al. Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failure. ESC Heart Fail. 2022 Apr;9(2):822–33. https://doi.org/10.1002/ehf2.13848.CrossRefPubMedPubMedCentral

96.

Celano CM, Villegas AC, Albanese AM, Gaggin HK, Huffman JC. Depression and anxiety in heart failure: a review. Harv Rev Psychiatry. 2018;26(4):175–84. https://doi.org/10.1097/HRP.0000000000000162.CrossRefPubMedPubMedCentral

97.

Jha MK, Qamar A, Vaduganathan M, Charney DS, Murrough JW. Screening and management of depression in patients with cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(14):1827–45. https://doi.org/10.1016/j.jacc.2019.01.041.CrossRefPubMedPubMedCentral

98.

Angermann CE, Gelbrich G, Störk S, Gunold H, Edelmann F, Wachter R, et al. Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial. JAMA. 2016;315(24):2683–93. https://doi.org/10.1001/jama.2016.7635.CrossRefPubMed

99.

Freedland KE, Carney RM, Rich MW, Steinmeyer BC, Rubin EH. Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial. JAMA Intern Med. 2015;175:1773–82.CrossRefPubMedPubMedCentral

100.

Easton K, Coventry P, Lovell K, Carter LA, Deaton C. Prevalence and measurement of anxiety in samples of patients with heart failure: meta-analysis. J Cardiovasc Nurs. 2016;31(4):367–79. https://doi.org/10.1097/JCN.0000000000000265.CrossRefPubMedPubMedCentral

101.

Altemus M, Sarvaiya N, Neill EC. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol. 2014;35(3):320–30. https://doi.org/10.1016/j.yfrne.2014.05.004.CrossRefPubMedPubMedCentral

102.

Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety disorders and cardiovascular disease. Curr Psychiatry Rep. 2016;18:101.CrossRefPubMedPubMedCentral

103.

Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254–743. https://doi.org/10.1161/CIR.0000000000000950.CrossRefPubMed

104.

Blumenthal JA, Babyak MA, O'Connor C, Keteyian S, Landzberg J, Howlett J, et al. Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-action randomized trial. JAMA. 2012;308:465–74.CrossRefPubMedPubMedCentral

105.

Acree LS, Longfors J, Fjeldstad AS, Fjeldstad C, Schank B, Nickel KJ, et al. Physical activity is related to quality of life in older adults. Health Qual Life Outcomes. 2006;4:37.CrossRefPubMedPubMedCentral

106.

O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. for the HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1439–50.CrossRefPubMedPubMedCentral

107.

Piña IL, Bittner V, Clare RM, Swank A, Kao A, Safford R, et al. Effects of exercise training on outcomes in women with heart failure: analysis of HF-ACTION (Heart Failure-A Controlled Trial Investigating Outcomes Of Exercise Training) by sex. J Am Coll Cardiol HF. 2014;2:180–6.

108.

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993–1004. https://doi.org/10.1056/NEJMoa1409077.CrossRefPubMed

109.

Billingsley HE, Hummel SL, Carbone S. The role of diet and nutrition in heart failure: a state-of-the-art narrative review. Prog Cardiovasc Dis. 2020 Sep-Oct;63(5):538–51. https://doi.org/10.1016/j.pcad.2020.08.004.CrossRefPubMedPubMedCentral

110.

Tektonidis TG, Akesson A, Gigante B, Wolk A, Larsson SC. Adherence to a Mediterranean diet is associated with reduced risk of heart failure in men. Eur J Heart Fail. 2016;18(3):253–9.CrossRefPubMed

111.

Tektonidis TG, Åkesson A, Gigante B, Wolk A, Larsson SC. A Mediterranean diet and risk of myocardial infarction, heart failure and stroke: a population-based cohort study. Atherosclerosis. 2015;243(1):93–8.CrossRefPubMed

112.

Martínez-González MA. Benefits of the Mediterranean diet beyond the Mediterranean Sea and beyond food patterns. BMC Med. 2016;14(1):157. https://doi.org/10.1186/s12916-016-0714-3.CrossRefPubMedPubMedCentral

113.

Levitan EB, Lewis CE, Tinker LF, Eaton CB, Ahmed A, Manson JE, et al. Mediterranean and DASH diet scores and mortality in women with heart failure. Circ Hear Fail. 2013;6(6):1116–23.CrossRef

114.

Del Gobbo LC, Kalantarian S, Imamura F, Lemaitre R, Siscovick DS, Psaty BM, et al. Contribution of major lifestyle risk factors for incident heart failure in older adults: the Cardiovascular Health Study. JACC Heart Fail. 2015;3(7):520–8.CrossRefPubMedPubMedCentral

115.

McKeag NA, McKinley MC, Woodside JV, Harbinson MT, McKeown PP. The role of micronutrients in heart failure. J Acad Nutr Diet. 2012;112(6):870–86. https://doi.org/10.1016/j.jand.2012.01.016.CrossRefPubMed

116.

Skipina TM, Upadhya B, Soliman EZ. Secondhand smoke exposure is associated with prevalent heart failure: longitudinal examination of the National Health and Nutrition Examination Survey. Nicotine Tob Res. 2021;23(9):1512–7. https://doi.org/10.1093/ntr/ntab047.CrossRefPubMed

117.

He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161(7):996–1002. https://doi.org/10.1001/archinte.161.7.996.CrossRefPubMed

118.

Dorans KS, Mostofsky E, Levitan EB, Håkansson N, Wolk A, Mittleman MA. Alcohol and incident heart failure among middle-aged and elderly men: cohort of Swedish men. Circ Heart Fail. 2015;8(3):422–7. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001787.CrossRefPubMedPubMedCentral

119.

Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331–78. https://doi.org/10.1161/CIR.0b013e3181dbece1.CrossRefPubMed

120.

de Bont J, Jaganathan S, Dahlquist M, Persson Å, Stafoggia M, Ljungman P. Ambient air pollution and cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses. J Intern Med. 2022;291(6):779–800. https://doi.org/10.1111/joim.13467.CrossRefPubMedPubMedCentral

121.

Olais P, Faustini A, Stafoggia M, Berti G, Bisanti L, Cadum E, et al. EPIAIR Collaborative Group. Particulate air pollution and hospital admissions for cardiac diseases in potentially sensitive subgroups. Epidemiology. 2012;23(3):473–81. https://doi.org/10.1097/EDE.0b013e31824d5a85.CrossRef

122.

Barnett AG, Williams GM, Schwartz J, Best TL, Neller AH, Petroeschevsky AL, et al. The effects of air pollution on hospitalizations for cardiovascular disease in elderly people in Australian and New Zealand cities. Environ Health Perspect. 2006;114(7):1018–23. https://doi.org/10.1289/ehp.8674.CrossRefPubMedPubMedCentral

Title: Heart Failure in the Elderly: the Role of Biological and Sociocultural Aspects Related to Sex
Authors: Pablo Díez-Villanueva
César Jiménez-Méndez
María Thiscal López-Lluva
Samantha Wasniewski
Jorge Solís
Leticia Fernández-Friera
Manuel Martínez-Sellés
Publication date: 27-07-2023
Publisher: Springer US
Keyword: Heart Failure
Published in: Current Heart Failure Reports / Issue 5/2023
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI: https://doi.org/10.1007/s11897-023-00619-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 5/2023

Telemedicine: an Effective and Low-Cost Lesson From the COVID-19 Pandemic for the Management of Heart Failure Patients

Multimorbidity in Heart Failure: Leveraging Cluster Analysis to Guide Tailored Treatment Strategies

Biomarkers in light chain cardiac amyloidosis

Coordinated Metabolic Responses Facilitate Cardiac Growth in Pregnancy and Exercise

Novel Therapeutic Strategies in Heart Failure in Adult Congenital Heart Disease: of Medicines and Devices

Do Heart Failure Biomarkers Influence Heart Failure Treatment Response?

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials